Sequoia Financial Advisors’s Revolution Medicines RVMD Stock Holding History

Sequoia Financial Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$626K	Buy	+3,342	New	+$488K	﹤0.01%	1196

Other funds holding RVMD

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

WPC

Wedmont Private Capital West Chester, Pennsylvania $3.65B AUM 26.64% 1-Year Est. Return

IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

SAM

Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

SCA

Sandy Cove Advisors Hingham, Massachusetts $400M AUM 27.68% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

SMDAM

Sumitomo Mitsui DS Asset Management Tokyo, Japan $14.5B AUM 37.68% 1-Year Est. Return

Sequoia Financial Advisors's RVMD Position: Q2 2026 in Review

Sequoia Financial Advisors opened a new position in Revolution Medicines (RVMD) in Q2 2026: 3,342 shares worth $626K. The stake represents ﹤0.01% of the portfolio and ranks #1196 among its holdings.

107 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

Sequoia Financial Advisors held 3,342 shares of Revolution Medicines worth $626K as of Q2 2026.
Revolution Medicines was a new Sequoia Financial Advisors position in Q2 2026.
Revolution Medicines made up ﹤0.01% of Sequoia Financial Advisors's portfolio in Q2 2026, its #1196 holding.
107 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.